LONGEVITY HEALTH HOLDINGS IN (XAGE) Stock Price, Quote, News and Overview
NASDAQ:XAGE - Nasdaq - US1429221039 - Common Stock - Currency: USD
XAGE Quote, Performance and Key Statistics
2.38
-1.07 (-31.01%)
The current stock price of XAGE is 2.38 USD. In the past month the price decreased by -51.68%.
XAGE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.84 | 324.18B | ||
| AMGN | AMGEN INC | 13.09 | 146.06B | ||
| GILD | GILEAD SCIENCES INC | 13.87 | 133.68B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 112.09B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.28 | 63.52B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 37.72B | ||
| ARGX | ARGENX SE - ADR | 100.1 | 35.88B | ||
| ONC | BEIGENE LTD-ADR | 6 | 26.02B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.72B | ||
| NTRA | NATERA INC | N/A | 20.84B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 19.20B | ||
| BIIB | BIOGEN INC | 7.95 | 18.43B |
Related stock screener links
About XAGE
Company Profile
Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 15 full-time employees. The company went IPO on 2021-07-29. The firm has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity.
Company Info
LONGEVITY HEALTH HOLDINGS IN
2403 Sidney Street, Suite 300
Pittsburgh PENNSYLVANIA US
Employees: 15
Phone: 14128948248
LONGEVITY HEALTH HOLDINGS IN / XAGE FAQ
What is the stock price of LONGEVITY HEALTH HOLDINGS IN today?
The current stock price of XAGE is 2.38 USD. The price decreased by -31.01% in the last trading session.
What is the ticker symbol for LONGEVITY HEALTH HOLDINGS IN stock?
The exchange symbol of LONGEVITY HEALTH HOLDINGS IN is XAGE and it is listed on the Nasdaq exchange.
On which exchange is XAGE stock listed?
XAGE stock is listed on the Nasdaq exchange.
What is LONGEVITY HEALTH HOLDINGS IN worth?
LONGEVITY HEALTH HOLDINGS IN (XAGE) has a market capitalization of 71.69M USD. This makes XAGE a Micro Cap stock.
How many employees does LONGEVITY HEALTH HOLDINGS IN have?
LONGEVITY HEALTH HOLDINGS IN (XAGE) currently has 15 employees.
What are the support and resistance levels for LONGEVITY HEALTH HOLDINGS IN (XAGE) stock?
LONGEVITY HEALTH HOLDINGS IN (XAGE) has a resistance level at 4.13. Check the full technical report for a detailed analysis of XAGE support and resistance levels.
Should I buy LONGEVITY HEALTH HOLDINGS IN (XAGE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of XAGE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of XAGE, evaluating the profitability, health, valuation and growth aspects
- LONGEVITY HEALTH HOLDINGS IN (XAGE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LONGEVITY HEALTH HOLDINGS IN (XAGE) Sales and EPS estimates to see what analysts future expectations are.
- LONGEVITY HEALTH HOLDINGS IN (XAGE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LONGEVITY HEALTH HOLDINGS IN (XAGE) Insider and Institutional Ownership to learn about the owners and their transactions.
- LONGEVITY HEALTH HOLDINGS IN (XAGE) Stock Chart to make your own analysis
- LONGEVITY HEALTH HOLDINGS IN (XAGE) Latest news and press-releases to stay up to date.
Does LONGEVITY HEALTH HOLDINGS IN (XAGE) stock pay dividends?
XAGE does not pay a dividend.
What is the Price/Earnings (PE) ratio of LONGEVITY HEALTH HOLDINGS IN (XAGE)?
LONGEVITY HEALTH HOLDINGS IN (XAGE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.5).
What is the Short Interest ratio of LONGEVITY HEALTH HOLDINGS IN (XAGE) stock?
The outstanding short interest for LONGEVITY HEALTH HOLDINGS IN (XAGE) is 1.82% of its float. Check the ownership tab for more information on the XAGE short interest.
XAGE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to XAGE.
XAGE Financial Highlights
Over the last trailing twelve months XAGE reported a non-GAAP Earnings per Share(EPS) of -0.5. The EPS increased by 74.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -703.41% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |